CAAS Capital Management’s Xilio Therapeutics XLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,019	Closed	-$592K	–	630
2021 Q4	$592K	Buy	+37,019	New	+$592K	0.01%	212